Taylor & Francis

Journal of Chemotherapy Template

Write in a clean editor, then format for Journal of Chemotherapy in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Journal of Chemotherapy format

Journal of Chemotherapy is a peer-reviewed journal published by Taylor & Francis, covering Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Pneumonia and Respiratory Infections.

PublisherTaylor & Francis
Reference styleAuthor–year (Chicago, T&F)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Chemotherapy 12 (3): 45–58.

Formats any DOI in Journal of Chemotherapy style. No sign-up.

Publishes research inAntibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Pneumonia and Respiratory Infections Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing
ISSN1120-009X
Citation impact (2-yr)2.19
h-index67
i10-index1,431
Total citations44,523
Top institutions publishing hereUniversity of Florence
Journal websitewww.tandfonline.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Journal of Chemotherapy per year

78
2014
83
2015
62
2016
51
2017
40
2018
61
2019
86
2020
84
2021
80
2022
73
2023
95
2024
75
2025

Citation impact of Journal of Chemotherapy by publication year

1.1K
2014
1.3K
2015
675
2016
1.2K
2017
552
2018
826
2019
961
2020
753
2021
591
2022
313
2023
340
2024
78
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Journal of Chemotherapy

Methylene Blue - a Therapeutic Dye for All Seasons?

Mark Wainwright, Kent Crossley · 1 Jan 2002

Since it was first synthesised in 1876, Methylene Blue (MB) has found uses in many different areas of clinical medicine, ranging from dementia to cancer chemotherapy. In addition, MB formed the basis of antimicrobial chemotherapy--particularly in the area of antimalarials--and eventually led to the discovery of the neuroleptic drug families. More recently, the photosensitising potential…

Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review

Annarita Mazzariol, Alda Bazaj, Giuseppe Cornaglia · 22 Dec 2017

Urinary tract infections (UTIs) are among the most frequent infectious diseases affecting humans, and represent an important public health problem with a substantial economic burden. Due to the high empiric use of antibiotics for the treatment of UTI, antibacterial resistance of Enterobacteriaceae, specifically the main uropathogens Escherichia coli and Klebsiella pneumoniae, has significantly increased worldwide.…

Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi

Mary E. Brandt, David W. Warnock · 1 Jan 2003

The dematiaceous (brown-pigmented) fungi are a large and heterogenous group of moulds that cause a wide range of diseases including phaeohyphomycosis, chromoblastomycosis, and eumycotic mycetoma. Among the more important human pathogens are Alternaria species, Bipolaris species, Cladophialophora bantiana, Curvularia species, Exophiala species, Fonsecaea pedrosoi, Madurella species, Phialophora species, Scedosporium prolificans, Scytalidium dimidiatum, and Wangiella dermatitidis.…

Amphotericin B-Induced Nephrotoxicity: A Review

Vassilios Fanos, L Cataldi · 1 Jan 2000

Amphotericin B is the gold standard for antifungal treatment for the most severe mycoses. However, adverse effects are common, with nephrotoxicity being the most serious, occurring early in the course of treatment, and usually being reversible in most patients. Tubular damage is a well known problem associated with amphotericin B therapy but acute renal failure…

Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin

Pornngarm Limtrakul, Orawan Khantamat, Komsak Pintha · 1 Feb 2005

The 170 kDa plasma membrane P-glycoprotein (Pgp) causes the efflux of chemotherapeutic drugs from cells and is believed to be an important mechanism in multidrug resistance (MDR) in human cancer. This study demonstrates that some putative flavonoids, i.e., flavonols (quercetin and kaempferol) and isoflavones (genistein and daidzein) markedly increase the sensitivity of the multidrug-resistant human…

Journal of Chemotherapy template — frequently asked questions

How do I write a paper in the Journal of Chemotherapy format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Journal of Chemotherapy template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Journal of Chemotherapy use?
Journal of Chemotherapy uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Chemotherapy 12 (3): 45–58.
Do I need to know LaTeX to submit to Journal of Chemotherapy?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready Journal of Chemotherapy document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Journal of Chemotherapy template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Journal of Chemotherapy format with correct headings, figures, tables, and author–year citations.
Who publishes Journal of Chemotherapy?
Journal of Chemotherapy is a multidisciplinary journal published by Taylor & Francis. DocuGuru's Journal of Chemotherapy template matches Taylor & Francis's official submission format.
Can I export a submission-ready Journal of Chemotherapy PDF?
Yes — DocuGuru produces a PDF built with the official Journal of Chemotherapy template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the Journal of Chemotherapy template cost?
You can start writing in the Journal of Chemotherapy template for free. Exporting the final submission-ready Journal of Chemotherapy PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Journal of Chemotherapy template